Gagny, France

Gilles Lebourg

This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2006-2007.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Gilles Lebourg

Introduction

Gilles Lebourg is a notable inventor based in Gagny, France. He has made significant contributions to the field of antifungal agents, holding a total of 2 patents. His work focuses on the development of echinocandin derivatives, which have important applications in medicine.

Latest Patents

Gilles Lebourg's latest patents include innovative compounds that exhibit antifungal properties. The first patent details derivatives of echinocandine, their preparation process, and their use as antifungals. The compounds of formula (I) described in this patent are presented in all possible isomer forms as well as their mixtures. The second patent also revolves around echinocandin derivatives, outlining a method for preparing these compounds and their application as antifungal agents. Similar to the first, this patent emphasizes the compounds of formula (I) and their antifungal properties.

Career Highlights

Gilles Lebourg is associated with Aventis Pharma S.A., a company known for its pharmaceutical innovations. His work at Aventis has allowed him to focus on developing effective antifungal treatments, contributing to advancements in medical science.

Collaborations

Throughout his career, Gilles has collaborated with esteemed colleagues such as Patrick Fauveau and Stephen Hawser. These collaborations have likely enriched his research and contributed to the success of his inventions.

Conclusion

Gilles Lebourg's contributions to the field of antifungal agents through his patents highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the development of effective treatments for fungal infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…